Excitatory and Inhibitory Actions of Isoprostanes in Human and
Canine Airway Smooth Muscle
1
LUKE J. JANSSEN, MAHMOOD PREMJI, STUART NETHERTON, ADRIANNA CATALLI, GERARD COX,
SHAF KESHAVJEE, and DENIS J. CRANKSHAW
Asthma Research Group, Father Sean O’Sullivan Research Centre, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
(L.J.J., M.P., S.N., A.C., G.C.); Toronto Lung Transplant Program, Division of Thoracic Surgery, University of Toronto, Ontario, Canada (S.K.);
and Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada (D.J.C.)
Accepted for publication July 11, 2000 This paper is available online at http://www.jpet.org
ABSTRACT
Isoprostanes are generated nonenzymatically during free radi-
cal-mediated lipid peroxidation, and are used clinically and
experimentally as markers of oxidative stress. However, their
biological effects are poorly understood. We examined the
effects of seven different 8-isoprostanes in human and canine
airway smooth muscles. In large order airways (carina) of the
human, several isoprostanes evoked powerful contractions,
with 8-iso-prostaglandin (PG) E
2
, 8-iso-PGF
1
, and 8-iso-
PGF
2
being the most efficacious (and with logEC
50
values of
7.0, 5.9, and 6.2 M, respectively). These contractions were
sensitive to the prostanoid TP receptor antagonist ICI 192,605
(0.1–1 M), but not the EP prostanoid receptor antagonist
AH-6809 (50 M), or the leukotriene receptor antagonists mon-
teleukast or ICI 198,615 (both 1 M). Qualitatively similar results
were obtained in small order human airways (2 mm o.d.),
except that the isoprostanes were generally slightly less potent.
None of the isoprostanes had any marked excitatory effect in
canine airways. In carbachol-preconstricted tissues (pretreated
with ICI 192,605 to block any potential contraction), several
isoprostanes completely relaxed canine airways: 8-iso-PGE
1
,
8-iso-PGE
2
, and 8-iso-PGF
3
were the most potent, with
logIC
50
values of 6.9, 6.9, and 5.7, respectively. Only 8-iso-
PGF
3
relaxed human airways (logIC
50
= 4.9). Our results show
that several 8-isoprostanes are highly biologically active in hu-
man and canine airways, evoking both excitatory and/or inhib-
itory effects, and that these effects are compound, species, and
tissue dependent.
The airways are continually exposed to a variety of free
radicals and reactive oxygen species in inspired air (e.g.,
ozone) and liberated by inflammatory cells (e.g., peroxide,
superoxide, hydroxyl radical). These agents can alter airway
function, ranging from contraction in human airways (Rabe
et al., 1995) to relaxation in canine airways (Gao and Van-
houtte, 1992; Janssen et al., 2000b), but the underlying
mechanisms are as yet unclear.
It is now recognized that nonenzymatic peroxidation of
arachidonic acid by free radicals and reactive oxygen species
can give rise to isoprostanes (Morrow et al., 1990; Practico et
al., 1995). Isoprostanes differ structurally from prostaglan-
dins (PGs) by the cis-orientation at the cyclopentane ring
junction compared with the trans-orientation in the classical
prostanoids (Fig. 1).
8-Isoprostanes are present in substantial amounts even in
normal plasma or urine (in which their levels can be several
orders of magnitude higher than those of cyclooxygenase-
derived PGs; Morrow et al., 1990), but they are further ele-
vated in many states in which oxidative stress is a prominent
feature. For example, they are elevated in smokers (Morrow
et al., 1995; Pratico et al., 1995; Delanty et al., 1996; Reilly et
al., 1996; Chiabrando et al., 1998; Pratico et al., 1998a); in
patients with asthma (Montuschi et al., 1999a), chronic ob-
structive pulmonary disease (Pratico et al., 1998b), intersti-
tial lung disease (Montuschi et al., 1998), cystic fibrosis
(Montuschi et al., 1999b), or acute chest syndrome (Klings et
al., 1999); during exposure to allergen (Dworski et al., 1999),
ozone (Hazbun et al.,1993), or hyperoxia (Vacchiano and
Tempel, 1994); and during ventilated ischemia (Becker et al.,
1998).
Despite their prevalence in these disease states, the bio-
logical effects of 8-isoprostanes in airways are very poorly
understood. 8-iso-PGF
2
is a potent stimulant of vascular
(Takahashi et al., 1992; Kang et al., 1993; Kromer and Tip-
pins, 1996; Zhang et al., 1996; John and Valentin, 1997;
Oliveira et al., 2000), intestinal (Elmhurst et al., 1997), and
uterine (Crankshaw, 1995) smooth muscles where its effects
are sensitive to selective prostanoid TP receptor antagonists.
Consequently, the effects of 8-iso-PGF
2
are generally, al-
though not exclusively, thought to be mediated by action at
Received for publication April 4, 2000.
1
This study was supported by an operating grant and a Scientist Award
from the Medical Research Council of Canada (to L.J.J.).
ABBREVIATIONS: PG, prostaglandin; HUA, human umbilical artery; PSS, physiological salt solution.
0022-3565/00/2952-0506$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 295, No. 2
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics 2785/856035
JPET 295:506–511, 2000 Printed in U.S.A.
506
at ASPET Journals on May 29, 2017 jpet.aspetjournals.org Downloaded from